162 related articles for article (PubMed ID: 35770457)
61. Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study.
Viktorin A; Levine SZ; Altemus M; Reichenberg A; Sandin S
BMJ; 2018 Jun; 361():k2233. PubMed ID: 29884724
[TBL] [Abstract][Full Text] [Related]
62. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Ban L; Tata LJ; Fiaschi L; Card T
Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
[TBL] [Abstract][Full Text] [Related]
63. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
Campos S; Portela F; Sousa P; Sofia C
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
[TBL] [Abstract][Full Text] [Related]
64. Cancer-Associated Chemotherapy Induces Less IBD Exacerbations and a Reduction of IBD Medication Afterwards.
Koc ÖM; van Kampen RJW; van Bodegraven AA
Inflamm Bowel Dis; 2018 Jun; 24(7):1606-1611. PubMed ID: 29669052
[TBL] [Abstract][Full Text] [Related]
65. Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study.
Wintzell V; Svanström H; Melbye M; Jess T; Olén O; Ludvigsson JF; Pasternak B
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):845-853. PubMed ID: 31494100
[TBL] [Abstract][Full Text] [Related]
66. Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
Khan N; Vallarino C; Lissoos T; Darr U; Luo M
Inflamm Bowel Dis; 2020 Feb; 26(3):462-468. PubMed ID: 30980714
[TBL] [Abstract][Full Text] [Related]
67. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
[TBL] [Abstract][Full Text] [Related]
68. Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis.
Yang C; Huang J; Huang X; Huang S; Cheng J; Liao W; Chen X; Wang X; Dai S
J Crohns Colitis; 2018 Aug; 12(9):1042-1052. PubMed ID: 29762681
[TBL] [Abstract][Full Text] [Related]
69. Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Ungaro RC; Brenner EJ; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
Gut; 2021 Apr; 70(4):725-732. PubMed ID: 33082265
[TBL] [Abstract][Full Text] [Related]
70. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
[TBL] [Abstract][Full Text] [Related]
71. Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting.
Imperatore N; Foggia M; Patturelli M; Rispo A; Calabrese G; Testa A; Pellegrini L; Tosone G; Di Luna I; Nardone OM; Ricciolino S; Castiglione F
J Gastroenterol Hepatol; 2021 Jul; 36(7):1859-1868. PubMed ID: 33283312
[TBL] [Abstract][Full Text] [Related]
72. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
73. Adverse events of IBD therapies.
Scribano ML
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S210-1. PubMed ID: 18816669
[No Abstract] [Full Text] [Related]
74. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.
Grijalva CG; Chen L; Delzell E; Baddley JW; Beukelman T; Winthrop KL; Griffin MR; Herrinton LJ; Liu L; Ouellet-Hellstrom R; Patkar NM; Solomon DH; Lewis JD; Xie F; Saag KG; Curtis JR
JAMA; 2011 Dec; 306(21):2331-9. PubMed ID: 22056398
[TBL] [Abstract][Full Text] [Related]
75. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
76. Earlier discontinuation of TNF-α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects.
Schultheiss JPD; Brand EC; Lamers E; van den Berg WCM; van Schaik FDM; Oldenburg B; Fidder HH
Aliment Pharmacol Ther; 2019 Aug; 50(4):386-396. PubMed ID: 31310690
[TBL] [Abstract][Full Text] [Related]
77. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
Chaparro M; Ramas M; Benítez JM; López-García A; Juan A; Guardiola J; Mínguez M; Calvet X; Márquez L; Fernández Salazar LI; Bujanda L; García C; Zabana Y; Lorente R; Barrio J; Hinojosa E; Iborra M; Cajal MD; Van Domselaar M; García-Sepulcre MF; Gomollón F; Piqueras M; Alcaín G; García-Sánchez V; Panés J; Domènech E; García-Esquinas E; Rodríguez-Artalejo F; Gisbert JP
Am J Gastroenterol; 2017 Jul; 112(7):1135-1143. PubMed ID: 28534520
[TBL] [Abstract][Full Text] [Related]
78. Advanced paternal age and mortality of offspring under 5 years of age: a register-based cohort study.
Urhoj SK; Jespersen LN; Nissen M; Mortensen LH; Nybo Andersen AM
Hum Reprod; 2014 Feb; 29(2):343-50. PubMed ID: 24316515
[TBL] [Abstract][Full Text] [Related]
79. Reversal of anti-drug antibodies against tumor necrosis factor inhibitors with addition of immunomodulators: A systematic review and meta-analysis.
Dhindsa BS; Dhaliwal A; Mashiana HS; Saghir SM; Sayles H; Mubder M; Ohning G; Eichele D
Indian J Gastroenterol; 2020 Apr; 39(2):153-160. PubMed ID: 32468382
[TBL] [Abstract][Full Text] [Related]
80. Do inflammatory bowel disease therapies cause cancer?
Mason M; Siegel CA
Inflamm Bowel Dis; 2013 May; 19(6):1306-21. PubMed ID: 23470503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
